title: Role of biomaterials in prevention of in-stent restenosis.
abstract: Coronary balloon angioplasty and coronary stenting are the procedures used in healing coronary artery disease. However, injury of arteries during angioplasty and stenting causes cell stimulations in tissue. Cell movement and thrombosis lead to re-narrowing of widened vessel called restenosis. Several new types of carriers and technology have been developed to suppress and/or prevent restenosis. Authors review the polymeric materials featured in drug/gene carrier systems, nanovehicles, and stent coating materials against restenosis.
authors.affiliation: Advanced Technology Education, Research and Application Center, Mersin University, 33343, Mersin, Turkey.
authors.forename: Nelisa T
authors.initials: NT
authors.lastname: Laçin
authors.forename: Guldem G
authors.initials: GG
authors.lastname: Utkan
mesh_terms: D000818:Animals; D020099:Coated Materials, Biocompatible / Q000737:chemistry / Q000627:therapeutic use*; D003324:Coronary Artery Disease / Q000378:metabolism / Q000473:pathology / Q000601:surgery*; D023903:Coronary Restenosis / Q000378:metabolism / Q000473:pathology / Q000517:prevention & control*; D006801:Humans; D015607:Stents
chemical_list: D020099:Coated Materials, Biocompatible
keywords: drug delivery; gene therapy; polymeric materials; restenosis